The intranasal route has proven to be a reliable and promising route for delivering
therapeutics to the central nervous system (CNS), averting the blood–brain barrier (BBB) …

Disorders related to central nervous system (CNS) like schizophrenia, Parkinson's disease,
and Alzheimer's disease need transport of the medication to the specific site in the brain for …

There is always a need for alternative and efficient methods of drug delivery. The nasal
cavity can be considered as a non-invasive and efficient route of administration. It has been …

Due to number of problems related with oral, parenteral, rectal and other routes of drug
administration, the interest of pharmaceutical scientists has increased towards exploring the …

The prevalence of neurological illnesses, such as epilepsy, Alzheimer's disease,
Parkinson's disease, glioblastoma, and multiple sclerosis, is rising globally; there is still a …

The use of nanocarriers for pharmaceutical and clinical applications is a well-established
archetype since long time. These nanoparticulate carriers are expected to stay in blood for …

Neurodegenerative diseases are a significant cause of mortality worldwide, and the blood–
brain barrier (BBB) poses a significant challenge for drug delivery. An intranasal route is a …

Context: Brain disorders remain the world's leading cause of disability, and account for more
hospitalizations and prolonged care than almost all other diseases combined. The majority …

Although the global prevalence of neurological disorders such as Parkinson's disease,
Alzheimer's disease, glioblastoma, epilepsy, and multiple sclerosis is steadily increasing …

We overviewed the anatomy and physiology of the nose-to-brain pathway, along with the
mechanisms involved. We then summarized the interaction process between nanoparticles …